Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Dacomitinib (PF299804,PF-00299804)
Cat No.
CEI-0074
Description
Dacomitinib (PF299804,PF-00299804) can inhibit ErbB1, ErbB2, and ErbB4.
CAS No.
1110813-31-4
Molecular Weight
469.94
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
ErbB1, ErbB2, ErbB4
Molecular Formula
C24H25ClFN5O2
Chemical Name
(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide
Solubility
DMSO 19 mg/mL Water
In vitro
As a potent, orally available, irreversible inhibitor of tyrosine kinase, PF299804 can inhibit epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4 with IC50 of 6.0, 45.7 and 73.7nM. Comparing PF299804 to the other three inhibitors (Gefitinib, Erlotinib, and CI-1033), PF299804 shows its characteristics.
In vivo
PF00299804 is effective in gefitinib-sensitive and gefitinib-resistant NSCLC cell lines.Whereas we observed a 70-fold range (4.1-306 nmol/L) in the IC50 for gefitinib against the five most common exon 19 deletions, the IC50 values were between 1 and 2 nmol/L for PF00299804 for all five mutations.
Download
Download Datasheet